AVANT IMMUNOTHERAPEUTICS INC, S-3, EX-23.1, 2000-08-07

AVANT IMMUNOTHERAPEUTICS INC
S-3, EX-23.1, 2000-08-07
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Previous: AVANT IMMUNOTHERAPEUTICS INC, S-3, EX-5.1, 2000-08-07

Next: AVANT IMMUNOTHERAPEUTICS INC, S-3, EX-99.3, 2000-08-07




<PAGE>

                                  EXHIBIT 23.1

                       CONSENT OF INDEPENDENT ACCOUNTANTS

     We hereby consent to the incorporation by reference in this Registration
Statement on Form S-3 of our report dated February 14, 2000 relating to the
financial statements which appears in AVANT Immunotherapeutics. Inc.'s Annual
Report on Form 10-K/A for the year ended December 31, 1999. We also consent
to the reference to us under the heading "Experts" in such Registration
Statement.

 /s/ PricewaterhouseCoopers LLP
------------------------------
PricewaterhouseCoopers LLP

PricewaterhouseCoopers LLP
Boston, Massachusetts
August 4, 2000